![Logo der Firma Immunic AG](http://cdn.pressebox.de/f/f790d90b6c75530a/logos/173149/500_500.gif)
Immunic enters into a global option and license agreement with Daiichi Sankyo
Immunic AG gains exclusive, worldwide rights to promising drug development program with novel target for treatment of in…
Immunic AG gains exclusive, worldwide rights to promising drug development program with novel target for treatment of in…
Written by the https://www.criticalinvestor.eu/... Introduction This time Kees Dekker analyzes Adriatic Metals, an A…
Human Insulin Market - Highlights Change in lifestyle and high prevalence of obesity is the root cause of widespread…
Ping Identity, the leader in Identity Defined Security, today announced the acquisition of API cybersecurity provider El…
AKDB increases the flexibility of municipal HR processes by modernizing application development. The company worked with…
Gartner, Inc. today highlighted the top technologies for information security and their implications for security organi…
Today, IBM (NYSE: IBM) launched the first suite of cognitive solutions to help financial institution professionals manag…
Every manufacturer fears errors in assembly. If defective screw connections result in product recall, the economic damag…
The German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG today announced a collaboration to utiliz…
Die KOGIT GmbH gründet gemeinsam mit Grabowsky BV aus den Niederlanden, ID North AB (ehemals Heimore AB) aus Schweden un…